Lung Cancer Screening in Family Members and Peers of Lung Cancer Patients: a Prospective Cohort Study
1 other identifier
observational
100
1 country
1
Brief Summary
Lung cancer screening of active or former heavy smokers with yearly low-dose CT allows for earlier diagnosis and better lung cancer survival. Risk of developing lung cancer is higher among family members and close contacts of lung cancer patients, because of shared genetics, environment and life habits like smoking. The investigators want to engage lung cancer patients to refer their family members and close contacts for lung cancer screening, and evaluate if this referred population have higher risk of lung cancer than the population referred by their family doctors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2022
CompletedFirst Posted
Study publicly available on registry
December 9, 2022
CompletedStudy Start
First participant enrolled
May 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedAugust 11, 2025
August 1, 2025
11 months
December 1, 2022
August 6, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Mean number of referrals for lung cancer screening per participants
Mean number of referrals for lung cancer screening per participants: lung cancer participants will refer contacts directly on the REDCap questionnaire at enrollment. They will be contacted a second time 2 weeks after enrollment and asked if they referred additional people in their entourage for lung cancer screening.
2 weeks post inclusion
Mean PLCOm2012 risk prediction model score among referred participants
Mean risk of developing lung cancer in the next 6 years using the validated PLCOm2012 risk prediction model in smokers or ex-smokers referred participants that are 55 to 74 years old.
baseline
Secondary Outcomes (9)
Number of visitors on our website for referred participants
6 months
Number of people who started to fill the enrollment form for referred participants.
6 months
Number of referred participants who enrolled in the study.
6 months
PLCO score as a binary outcome (above or below 2%) among referred participants
baseline
Proportion of LCS eligible participants who will complete lung cancer screening within 18 months of referral by a lung cancer patient
18 months
- +4 more secondary outcomes
Study Arms (2)
Lung cancer patient
Lung cancer patients or lung cancer survivors willing to refer close contacts for lung cancer screening
Referred participants
Participants referred to the study by close contacts living with lung cancer.
Eligibility Criteria
1. Lung cancer patient recruited at clinics at the MUHC. 2. Close contacts of lung cancer patients referred to our study
You may qualify if:
- \> 18 years old
- Current or former lung cancer patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MUHC
Montreal, Quebec, Canada
Related Publications (1)
Pitrou I, Petrangelo A, Besson C, Pepe C, Waschke AH, Agulnik J, Gonzalez AV, Ezer N. Lung Cancer Screening in Family Members and Peers of Patients With Lung Cancer: Protocol for a Prospective Cohort Study. JMIR Res Protoc. 2025 Mar 28;14:e58529. doi: 10.2196/58529.
PMID: 40153794DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicole Ezer, MD
Research Institute of the McGill University Health Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant professor of medicine
Study Record Dates
First Submitted
December 1, 2022
First Posted
December 9, 2022
Study Start
May 12, 2023
Primary Completion
April 1, 2024
Study Completion
April 1, 2025
Last Updated
August 11, 2025
Record last verified: 2025-08